An updated review of the molecular mechanisms in drug hypersensitivity
Drug hypersensitivity may manifest ranging from milder skin reactions (eg, maculopapular
exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions …
exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions …
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …
D Khanna, JD Fitzgerald, PP Khanna… - Arthritis care & …, 2012 - Wiley Online Library
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
HLA-B* 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SI Hung, WH Chung, LB Liou, CC Chu… - Proceedings of the …, 2005 - National Acad Sciences
Allopurinol, a commonly prescribed medication for gout and hyperuricemia, is a frequent
cause of severe cutaneous adverse reactions (SCAR), which include the drug …
cause of severe cutaneous adverse reactions (SCAR), which include the drug …
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28‐week, phase III, randomized, double‐blind …
HR Schumacher Jr, MA Becker… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To compare the urate‐lowering efficacy and safety of febuxostat, allopurinol, and
placebo in a large group of subjects with hyperuricemia and gout, including persons with …
placebo in a large group of subjects with hyperuricemia and gout, including persons with …
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol
LK Stamp, WJ Taylor, PB Jones… - Arthritis & …, 2012 - Wiley Online Library
Objective Allopurinol is the most commonly used urate‐lowering therapy in gout. Allopurinol
hypersensitivity syndrome (AHS) is a rare but potentially fatal adverse event. Dosing …
hypersensitivity syndrome (AHS) is a rare but potentially fatal adverse event. Dosing …
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
S Halevy, PD Ghislain, M Mockenhaupt… - Journal of the American …, 2008 - Elsevier
BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)
are rare severe cutaneous adverse reactions. OBJECTIVES: We sought to update …
are rare severe cutaneous adverse reactions. OBJECTIVES: We sought to update …
Dietary flavonoids as xanthine oxidase inhibitors: Structure–affinity and structure–activity relationships
S Lin, G Zhang, Y Liao, J Pan… - Journal of agricultural and …, 2015 - ACS Publications
The flavonoid family has been reported to possess a high potential for inhibition of xanthine
oxidase (XO). This study concerned the structural aspects of inhibitory activities and binding …
oxidase (XO). This study concerned the structural aspects of inhibitory activities and binding …
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase
Y Takano, K Hase-Aoki, H Horiuchi, L Zhao… - Life sciences, 2005 - Elsevier
The purine analogue, allopurinol, has been in clinical use for more than 30 years as an
inhibitor of xanthine oxidase (XO) in the treatment of hyperuricemia and gout. As …
inhibitor of xanthine oxidase (XO) in the treatment of hyperuricemia and gout. As …
Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and …
WH Chung, WC Chang, SL Stocker, CG Juo… - Annals of the …, 2015 - ard.bmj.com
Objective Allopurinol, an antihyperuricaemic agent, is one of the common causes of life-
threatening severe cutaneous adverse reactions (SCAR), including drug rash with …
threatening severe cutaneous adverse reactions (SCAR), including drug rash with …
Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase
Y Chen, Z Zhao, Y Li, Y Yang, L Li, Y Jiang, C Lin… - Phytomedicine, 2021 - Elsevier
Background Insufficient renal urate excretion and/or overproduction of uric acid (UA) are the
dominant causes of hyperuricemia. Baicalein (BAL) is widely distributed in dietary plants …
dominant causes of hyperuricemia. Baicalein (BAL) is widely distributed in dietary plants …